Parasite Epidemiology and Control

PARASITE EPIDEMIOLOGY AND CONTROL

AUTHOR INFORMATION PACK

TABLE OF CONTENTS

XXX

.

••••
Description Abstracting and Indexing Editorial Board p.1 p.1 p.1

p.4

Guide for Authors

ISSN: 2405-6731

DESCRIPTION

.

Parasite Epidemiology and Control is an Open Access journal.

There is increased parasitology research that analyses the patterns, causes, and effects of health and disease conditions in defined populations. This epidemiology of parasite infectious diseases is predominantly studied in human populations but also includes other major hosts of parasitic infections and as such this journal has broad remit. Parasite Epidemiology and Control focuses on the major areas of epidemiological study including disease etiology, disease surveillance, drug resistance, geographical spread, screening, biomonitoring, and comparisons of treatment effects in clinical trials for both human and other animals. We also focus on the epidemiology and control of vector insects. The journal also covers the use of geographic information systems (Epi-GIS) for epidemiological surveillance which is a rapidly growing area of research in infectious diseases. Molecular epidemiological approaches are also particularly encouraged.

ABSTRACTING AND INDEXING

.

PubMed Central Directory of Open Access Journals (DOAJ) Google Scholar ScienceDirect Scopus

EDITORIAL BOARD

.

Founding Editor

Marcel Tanner, Swiss Tropical and Public Health Institute, Basel, Switzerland

Epidemiology and control, health systems, one-health, global public health

Editors

Uwemedimo Friday Ekpo, Federal University of Agriculture Abeokuta Department of Pure and Applied Zoology, Abeokuta, Nigeria

Tropical Parasitic Diseases, Schistosomiasis, Malacology, Vector Control, Epidemiological Disease Mapping, Behavioral Changes, One health

Pikka Jokelainen, State Serum Institute, Department of Bacteria, Parasites and Fungi, Infectious Disease Preparedness, Laboratory of Parasitology, Copenhagen, Denmark

AUTHOR INFORMATION PACK 27 Sep 2021

www.elsevie r .com/locate/parepi

1

Zoonotic parasites, Toxoplasma gondii, One health

Olumide Ogundahunsi, University of Medical Sciences, Ondo, Nigeria

Tropical diseases, malaria, implementation research, pharmacology &, therapeutics

Juan David Ramírez, Universidad del Rosario, Center for Research in Microbiology and Biotechnology-UR (CIMBIUR), Bogota, Colombia

Chagas disease, leishmaniasis, intestinal parasites, disease ecology, molecular diagnosis, disease evolution, genomics, transcriptomics

Tai-Soon Yong, Yonsei University Institute of Tropical Medicine, Seoul, South Korea

Systematics, ecology and the control of disease vectors, diagnosis technologies

Editorial Board Members

Jean Louis Abdourahim Ndiaye, University of Thies, Thies, Senegal

Malaria epidemiology and control, public health, malaria in pregnancy, seasonal malaria chemoprevention

Jeffrey M. Bethony, The George Washington University, Washington, District of Columbia, United States of America

Vaccines, cancer biomarkers, biobanking and biorepositories, clinical trials, HIV/AIDS, HIV/AIDsassociated malignancies

Fred Binka, World Health Organization Representative Office Cambodia, Phnom Penh, Cambodia

Clinical epidemiology, infectious disease epidemiology, measurement

Pascal Boireau, National Agency for Food Environmental and Occupational Health and Safety, Maisons Alfort, France

Foodborne parasites

Jong-Yil Chai, Seoul National University College of Medicine Department of Tropical Medicine and Parasitology, Seoul, South Korea

Intestinal parasites, Diagnostic parasitology, Zoonotic trematodes, Clinical parasitology, Toxoplasmosis and Cryptosporidiosis

Alan Cowman, Walter and Eliza Hall Institute of Medical Research Infectious Diseases and Immune Defence Division, Parkville, Victoria, Australia

Malaria, cell biology, vaccine and anti-malarial drug development

Liwang Cui, The Pennsylvania State University, University Park, United States of America

Malaria functional genomics, drug devleopment, epidemiology and control

Ananias Escalante, Temple University, Philadelphia, Pennsylvania, United States of America

Molecular epidemiology of infectious diseases, disease ecology, evolutionary genetics, comparative genomics

Marcelo Urbano Ferreira, University of Sao Paulo, São Paulo, Brazil

Malaria epidemiology and control, population genetics of malaria parasites, naturally acquired immunity to parasites

Felipe Guhl, University of Los Andes Department of Biological Sciences, Bogotá, Colombia

Tropical Parasitology, neglected diseases, molecular biology, control strategies, chagas disease

Peter Hotez, Baylor College of Medicine, Houston, Texas, United States of America

Vaccinology, neglected tropical diseases, public policy, hookworm, coronavirus

Panagiotis Karanis, University of Cologne, Cologne, Germany

Water, Food, Vector, Airborne Parasitic and Tropical Diseases

Jacob Koella, University of Neuchâtel, Neuchatel, Switzerland

Theoretical epidemiology, evolutionary ecology of parasites, malaria-mosquito interactions

Kwadwo Koram, University of Ghana Noguchi Memorial Institute for Medical Research, Accra, Ghana

Malaria epidemiology and control, drug resistance

Jørgen A. L. Kurtzhals, University of Copenhagen, Copenhagen, Denmark

Malaria pathogenesis and treatment, parasite diagnostics, interactions between nutrition and infections, infection control, international health

Marcus Lacerda, University of Amazonas State, MANAUS, Brazil

Infectious diseases, Plasmodium vivax, anti-malarial drugs

Shi-Zhu Li, National Institute of Parasitic Diseases, Shanghai, China

Parasitic Disease Control, Schistosomiasis Control, epidemiology, phylogenetic, snail population genetics

Lisette van Lieshout, Leiden University Medical Center Department of Parasitology, Leiden, Netherlands

Epidemiology and control, health systems, one-health, global public health

Santiago Mas-Coma, University of Valencia, Valencia, Spain

Neglected tropical diseases, helminthic diseases, food-borne trematodiases, fascioliasis, vector-borne diseases, molluscan and arthropod vectors

Donald P McManus, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia

2

Schistosomiasis, Echinocococcosis, Intestinal worm infections, Diagnostics, Vaccines, Epidemiology, Health education

João Mesquita, University of Porto Institute of Biomedical Sciences Abel Salazar, Porto, Portugal

Molecular biology, epidemiology, vector-borne diseases

Francine Ntoumi, Congolese Foundation for Medical Research, Brazzaville, Congo

Malaria immunology and molecular epidemiology, infectious diseases

David Piedrafita, Federation University Australia School of Science Engineering and Information Technology Gippsland, Churchill, Australia

Immunology, vaccine development, Fasciola, veterinary parasitology

Men-Bao Qian, Chinese Center for Disease Control and Prevention, Beijing, China

Epidemiology and statistics, Helminthiases, Food-borne trematodiasis, Soil-transmitted helminthiasis, Taeniasis and cysticercosis

Antonieta Rojas de Arias, Center for the Development of Scientific Research, Asuncion, Paraguay

Chagas disease, Leishmaniasis, Malaria, Climate change, Ecoepidemiology

David Rollinson, Natural History Museum, London, United Kingdom

Schistosomiasis, control and elimination of neglected tropical diseases, population genetics and evolution

Christen Rune Stensvold, State Serum Institute, København, Denmark

Molecular epidemiology, diagnostics, intestinal Parasites, genetic diversity, microbiome

Sue Welburn, The University of Edinburgh, Edinburgh, United Kingdom

Neglected zoonotic diseases, one health, epidemiology, molecular epidemiology

Zhong Dao Wu, Sun Yat-Sen University, Guangzhou, China

Helminths, Schistosoma, epidemiology and control

Guiyan Yan, University of California Irvine, Irvine, California, United States of America

Vector-borne disease epidemiology, vector biology, malaria

Xiao-Nong Zhou, National Institute of Parasitic Diseases, Shanghai, China

Tropical diseases, Schistosomiasis, Malaria, Malacology, One health, Global health, Implementation research, Epidemiology, Modeling

Xing-Quan Zhu, Shanxi Agricultural University, College of Veterinary Medicine, Taigu, China

Parasite epidemiology, Diagnostics and control strategies, Parasite genetics, Genomics and functional omics, Molecular vaccines

3

GUIDE FOR AUTHORS

.

INTRODUCTION

There is an increasing amount of research in the parasitology area that analyses the patterns, causes, and effects of health and disease conditions in defined populations. This epidemiology of parasite infectious diseases is predominantly studied in human populations but also spans other major hosts of parasitic infections and as such this journal will have a broad remit. We will focus on the major areas of epidemiological study including disease etiology, disease surveillance, drug resistance and geographical spread and screening, biomonitoring, and comparisons of treatment effects in clinical trials for both human and other animals. We will also look at the epidemiology and control of vector insects. The journal will also cover the use of geographic information systems (EpiGIS) for epidemiological surveillance which is a rapidly growing area of research in infectious diseases. Molecular epidemiological approaches are also particularly encouraged.

The primary form of publication in the journal is a full-length paper describing scientifically-sound original research studies. Less than full-length publications include Brief Communications of original research findings, and Investigative Reports describing studies of unique single cases or widespread outbreaks. Review articles on specific high profile topics, emerging or strategic issues may be solicited by the journal for publication, but requests for such submissions may also be made. Topical review articles based on keynote presentations at conferences or workshops will be considered

General enquiries prior to submission should be directed to the Editorial Office: [email protected]

BEFORE YOU BEGIN

Ethics in publishing

Please see our information on Ethics in publishing. Studies involving animal experiments must meet the International Guiding Principles for Biomedical Research Involving Animals as issued by the Council for International Organizations of Medical Sciences. (Obtainable from: Executive Secretary C.I.O.M.S., c/o W.H.O., Via Appia, CH-1211 Geneva 27, Switzerland).

Declaration of interest

All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places: 1. A summary declaration of interest statement in the title page file (if double anonymized) or the manuscript file (if single anonymized). If there are no interests to declare then please state this: 'Declarations of interest: none'. 2. Detailed disclosures as part of a separate Declaration of Interest form, which forms part of the journal's official records. It is important for potential interests to be declared in both places and that the information matches. More information.

Submission declaration and verification

Submission of an article implies that the work described has not been published previously (except in the form of an abstract, a published lecture or academic thesis, see 'Multiple, redundant or concurrent publication' for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyrightholder. To verify originality, your article may be checked by the originality detection service Crossref

Similarity Check.

Use of inclusive language

Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Content should make no assumptions about the beliefs or commitments of any reader; contain nothing which might imply that one individual is superior to another on the grounds of age, gender, race, ethnicity, culture, sexual orientation, disability or health condition; and use inclusive language throughout. Authors should ensure that writing is free from bias, stereotypes, slang, reference to dominant culture and/or cultural assumptions. We advise to seek gender neutrality by using plural nouns ("clinicians, patients/clients") as default/wherever possible

4

to avoid using "he, she," or "he/she." We recommend avoiding the use of descriptors that refer to personal attributes such as age, gender, race, ethnicity, culture, sexual orientation, disability or health condition unless they are relevant and valid. These guidelines are meant as a point of reference to help identify appropriate language but are by no means exhaustive or definitive.

Changes to authorship

Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, the Editor must receive the following from the corresponding author: (a) the reason for the change in author list and (b) written confirmation (e-mail, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed. Only in exceptional circumstances will the Editor consider the addition, deletion or rearrangement of authors after the manuscript has been accepted. While the Editor considers the request, publication of the manuscript will be suspended. If the manuscript has already been published in an online issue, any requests approved by the Editor will result in a corrigendum.

Upon acceptance of an article, authors will be asked to complete an 'Exclusive License Agreement' where authors will retain copyright (for more information on this see https://www.elsevie r .com/OAauthoragreement.). Permitted reuse of open access articles is determined by the author's choice of user license (see https://www.elsevie r .com/openaccesslicenses).

Retained author rights

As an author you (or your employer or institution) retain certain rights, including copyright; for details

you are referred to https://www.elsevie r .com/OAauthoragreement.

Elsevier supports responsible sharing

Find out how you can share your research published in Elsevier journals. You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated.

Elsevier has established agreements and developed policies to allow authors whose articles appear in journals published by Elsevier, to comply with potential manuscript archiving requirements as specified as conditions of their grant awards. To learn more about existing agreements and policies please visit

https://www.elsevie r .com/fundingbodies.

Open access

Please visit our Open Access page for more information. This journal is fully open access; all articles will be immediately and permanently free for everyone to read and download upon publication. Permitted (re)use is defined by your choice of one of the following Creative Commons user licenses (see

https://www.elsevie r .com/about/policies/open-access-licenses):

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative Bworks of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation.

Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND): for non-

commercial purposes, lets others distribute and copy the article, and to include in a collective work (such as an anthology), as long as they credit the author(s) and provided they do not alter or modify the article.

5

To provide open access, this journal has an open access fee (also known as: open access publication fee) which needs to be met by the authors or their research funders. The open access fee is all inclusive, Elsevier will not add any additional charges. Depending on local regulations VAT can be charged by local authorities.